Establishment Labs Holdings Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Establishment Labs Holdings Inc. (ESTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-05-08
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $1.20M, a 1100.00% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $9.10M, a 1416.67% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-06-30 was $100.00K, a 95.83% decline year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $9.30M, a 126.83% increase from fiscal 2024.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $4.10M, a 19.61% decline from fiscal 2023.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $5.10M, a 66.00% decline from fiscal 2022.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $15.00M, a 47.74% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-08 | $10.30M derived: sum of 2 quarters · filed 2026-05-08 | $10.30M derived: sum of 3 quarters · filed 2026-05-08 | $10.40M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.10M derived: sum of 2 quarters · filed 2026-02-27 | $9.20M derived: sum of 3 quarters · filed 2026-02-27 | $9.30M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $100.00K derived: sum of 2 quarters · filed 2025-11-07 | $200.00K 10-Q · filed 2025-11-07 | $800.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $200.00K 10-Q · filed 2025-08-07 | $800.00K derived: sum of 3 quarters · filed 2026-05-08 | $800.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-08 | $700.00K derived: sum of 2 quarters · filed 2026-05-08 | $700.00K derived: sum of 3 quarters · filed 2026-05-08 | $3.10M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $600.00K derived: sum of 2 quarters · filed 2026-02-27 | $3.00M derived: sum of 3 quarters · filed 2026-02-27 | $4.10M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.40M derived: sum of 2 quarters · filed 2025-11-07 | $3.50M 10-Q · filed 2025-11-07 | $4.70M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.50M 10-Q · filed 2025-08-07 | $4.70M derived: sum of 3 quarters · filed 2026-02-27 | $5.40M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-09 | $2.30M derived: sum of 2 quarters · filed 2026-02-27 | $3.00M derived: sum of 3 quarters · filed 2026-02-27 | $3.70M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.90M derived: sum of 2 quarters · filed 2026-02-27 | $2.60M derived: sum of 3 quarters · filed 2026-02-27 | $5.10M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.40M derived: sum of 2 quarters · filed 2024-11-12 | $3.90M 10-Q · filed 2024-11-12 | $7.20M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.20M 10-Q · filed 2024-08-07 | $6.50M derived: sum of 3 quarters · filed 2025-02-28 | $11.30M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $2.50M 10-Q · filed 2024-05-09 | $5.80M derived: sum of 2 quarters · filed 2025-02-28 | $10.60M derived: sum of 3 quarters · filed 2025-02-28 | $12.50M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $8.10M derived: sum of 2 quarters · filed 2025-02-28 | $10.00M derived: sum of 3 quarters · filed 2025-02-28 | $15.00M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.70M derived: sum of 2 quarters · filed 2023-11-08 | $11.70M 10-Q · filed 2023-11-08 | $15.00M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2022-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.90M 10-Q · filed 2023-08-09 | $10.20M derived: sum of 3 quarters · filed 2024-03-04 | $26.10M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2022-03-31 | $5.00M 10-Q · filed 2023-05-10 | $8.30M derived: sum of 2 quarters · filed 2024-03-04 | $24.20M derived: sum of 3 quarters · filed 2024-03-04 | $26.40M derived: sum of 4 quarters · filed 2024-03-04 | |
| 2021-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $19.20M derived: sum of 2 quarters · filed 2024-03-04 | $21.40M derived: sum of 3 quarters · filed 2024-03-04 | $28.70M 10-K · filed 2024-03-04 | |
| 2021-09-30 | $15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $18.10M derived: sum of 2 quarters · filed 2022-11-09 | $25.40M 10-Q · filed 2022-11-09 | $26.30M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.50M 10-Q · filed 2022-08-09 | $10.40M derived: sum of 3 quarters · filed 2023-03-01 | $10.60M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $7.30M 10-Q · filed 2022-05-10 | $8.20M derived: sum of 2 quarters · filed 2023-03-01 | $8.40M derived: sum of 3 quarters · filed 2023-03-01 | $8.80M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.10M derived: sum of 2 quarters · filed 2023-03-01 | $1.50M derived: sum of 3 quarters · filed 2023-03-01 | $1.90M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $600.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.00M 10-Q · filed 2021-11-09 | $1.80M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $800.00K 10-Q · filed 2021-07-30 | $1.60M derived: sum of 3 quarters · filed 2022-03-01 | $1.85M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-06 | $1.20M derived: sum of 2 quarters · filed 2022-03-01 | $1.46M derived: sum of 3 quarters · filed 2022-03-01 | $1.84M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.05M derived: sum of 2 quarters · filed 2022-03-01 | $1.44M derived: sum of 3 quarters · filed 2022-03-01 | $1.50M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $641.00K derived: sum of 2 quarters · filed 2019-11-12 | $700.00K 10-Q · filed 2019-11-12 | $1.28M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $445.00K 10-Q · filed 2019-08-13 | $1.02M derived: sum of 3 quarters · filed 2020-03-16 | $2.02M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | $59.00K 10-Q · filed 2019-05-15 | $637.00K derived: sum of 2 quarters · filed 2020-03-16 | $1.64M derived: sum of 3 quarters · filed 2020-03-16 | $2.04M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.58M derived: sum of 2 quarters · filed 2020-03-16 | $1.98M derived: sum of 3 quarters · filed 2020-03-16 | $2.98M 10-K · filed 2020-03-16 | $3.00M 10-K · filed 2019-03-20 |
| 2018-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.40M derived: sum of 2 quarters · filed 2018-11-13 | $2.40M 10-Q · filed 2018-11-13 | $2.40M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2018-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-09-13 | $1.40M 10-Q · filed 2018-09-13 | $1.40M derived: sum of 3 quarters · filed 2019-05-15 | $1.40M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-15 | $1.00M derived: sum of 2 quarters · filed 2019-05-15 | $1.00M derived: sum of 3 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $0.00 derived: sum of 2 quarters · filed 2019-03-20 | $0.00 10-K · filed 2019-03-20 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |